Literature DB >> 2960772

The subdivision of the T4 (CD4) subset on the basis of the differential expression of L-C/T200 antigens.

C E Rudd1, C Morimoto, L L Wong, S F Schlossman.   

Abstract

The T4 (CD4) subset of T lymphocytes has been subdivided into two major subsets, a suppressor/inducer subset (T4+,2H4+) and a helper subset (T4+,2H4-) on the basis of the differential expression of the L-C/T200 (CD45) antigens. The 2H4 antigen itself comprises at least three distinct polypeptides at 125,200, and 220 X 10(3) Mr, of which the 200 and 220 X 10(3) Mr polypeptides constitute the highest Mr isoforms of a pool of five distinct L-C/T200 antigens. The T4+,2H4+ subset expresses at least four of these isoforms at 180, 190, 200, and 220 X 10(3) on the cell surface, while the T4+,2H4- subset expresses only the 180 and 190 X 10(3) Mr forms. Pulse-chase analysis and endoglycosidase treatment revealed that the 125 X 10(3) Mr chain of the 2H4 antigen is nonglycosylated, while the 200 and 220 X 10(3) polypeptides are structurally related and derived by N- and O-linked glycosylation from two nascent subunits at 150 and 160 X 10(3) Mr. The function of the T4+,2H4+ subset could be blocked only by an antibody reactive with the L-C/T200 isoforms enriched with O-linked oligosaccharides at 200 and 220 X 10(3) Mr.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2960772      PMCID: PMC2188802          DOI: 10.1084/jem.166.6.1758

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1.

Authors:  S H Smith; M H Brown; D Rowe; R E Callard; P C Beverley
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

2.  The cellular basis for the induction of antigen-specific T8 suppressor cells.

Authors:  C Morimoto; N L Letvin; J A Distaso; H M Brown; S F Schlossman
Journal:  Eur J Immunol       Date:  1986-02       Impact factor: 5.532

3.  The isolation and characterization of the human helper inducer T cell subset.

Authors:  C Morimoto; N L Letvin; A W Boyd; M Hagan; H M Brown; M M Kornacki; S F Schlossman
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

4.  NK-9, a distinct sialylated antigen of the T200 family.

Authors:  P Nieminen; E Saksela
Journal:  Eur J Immunol       Date:  1986-05       Impact factor: 5.532

5.  Cloning of Ly-5 cDNA.

Authors:  F W Shen; Y Saga; G Litman; G Freeman; J S Tung; H Cantor; E A Boyse
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

6.  Evidence from cDNA clones that the rat leukocyte-common antigen (T200) spans the lipid bilayer and contains a cytoplasmic domain of 80,000 Mr.

Authors:  M L Thomas; A N Barclay; J Gagnon; A F Williams
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

7.  Identification and isolation of OKT4+ suppressor cells with the monoclonal antibody WR16.

Authors:  K Moore; A M Nesbitt
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

8.  Acquisition of cytotoxic T lymphocyte-specific carbohydrate differentiation antigens.

Authors:  L Lefrancois; L Puddington; C E Machamer; M J Bevan
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

9.  T cells that help B cell responses to soluble antigen are distinguishable from those producing interleukin 2 on mitogenic or allogeneic stimulation.

Authors:  R P Arthur; D Mason
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

10.  Different classes of T lymphocytes have different mRNAs for the leukocyte-common antigen, T200.

Authors:  L Lefrancois; M L Thomas; M J Bevan; I S Trowbridge
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

View more
  33 in total

1.  Imbalance of CD4+ lymphocyte subsets in patients with mixed connective tissue disease.

Authors:  H Becker; A Langrock; K Federlin
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

2.  Selective deficiency of CD4+/CD45RA+ lymphocytes in patients with ataxia-telangiectasia.

Authors:  R Paganelli; E Scala; E Scarselli; C Ortolani; A Cossarizza; D Carmini; F Aiuti; M Fiorilli
Journal:  J Clin Immunol       Date:  1992-03       Impact factor: 8.317

3.  Pillars article: the CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes. 1988.

Authors:  Christopher E Rudd; James M Trevillyan; Jai Dev Dasgupta; Linda L Wong; Stuart F Schlossman
Journal:  J Immunol       Date:  2010-09-01       Impact factor: 5.422

4.  Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: II. Characterization of cells cultured ex vivo and their contribution to the in vivo immunomodulation.

Authors:  C Fortis; E Ferrero; M Biffi; S Heltai; C Besana; E Bucci; M Tresoldi; C Rugarli
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

5.  Specific interaction of the CD45 protein-tyrosine phosphatase with tyrosine-phosphorylated CD3 zeta chain.

Authors:  T Furukawa; M Itoh; N X Krueger; M Streuli; H Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

Review 6.  Regulation of IgA synthesis and immune response by T cells and interleukins.

Authors:  J R McGhee; J Mestecky; C O Elson; H Kiyono
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

7.  Progressive changes in CD45RB phenotype and lymphokine production by murine CD4+ T cells after alloantigen exposure.

Authors:  M L Birkeland; T Kraus; L Tardelli; E Puré
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

8.  The tetraspanin CD9 is preferentially expressed on the human CD4(+)CD45RA+ naive T cell population and is involved in T cell activation.

Authors:  H Kobayashi; O Hosono; S Iwata; H Kawasaki; M Kuwana; H Tanaka; N H Dang; C Morimoto
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

9.  Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system. 4. Effects of multiple-dose treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on peripheral lymphocyte subpopulations of a non-human primate (Callithrix jacchus).

Authors:  R Neubert; G Golor; R Stahlmann; H Helge; D Neubert
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

10.  Loss of naïve (CD45RA+) CD4+ lymphocytes during pediatric infection with feline immunodeficiency virus.

Authors:  Abigail D Carreño; Ayalew Mergia; Janelle Novak; Nazareth Gengozian; Calvin M Johnson
Journal:  Vet Immunol Immunopathol       Date:  2007-09-11       Impact factor: 2.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.